| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. | Director | Common Stock | 109K | $287K | $2.62 | 10 Jun 2025 | Direct |
| Akebia Therapeutics, Inc. | Director | Stock Option (Right to buy) | 53.6K | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | 10 Jun 2025 | 2 | $0 | 4 | Director | 11 Jun 2025, 17:16 |
| AKBA | Akebia Therapeutics, Inc. | 06 Jun 2024 | 2 | $0 | 4 | Director | 10 Jun 2024, 16:18 |
| AKBA | Akebia Therapeutics, Inc. | 06 Jun 2023 | 2 | $0 | 4 | Director | 08 Jun 2023, 16:08 |
| AKBA | Akebia Therapeutics, Inc. | 08 Jun 2022 | 2 | $0 | 4 | Director | 09 Jun 2022, 17:01 |